Roundhill Glp-1 & Weight Loss ETF (OZEM)

$26.58 +0.08 (0.30%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 14,604
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

StocktwitsNews
StocktwitsNews Feb. 12 at 10:21 AM
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report $NVO $OZEM $PPH https://stocktwits.com/news/equity/markets/novo-looks-to-ireland-to-scale-production-of-wegovy-pill-report/cZRT0F6R4rc
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 10 at 2:59 PM
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial $HOTH $HIMS $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/hoth-therapeutics-gdnf-treatment-shows-superior-efficacy-over-wegovy-ozempic-in-preclinical-trial/cZbUJr3R4p2
0 · Reply
wwmeinc
wwmeinc Feb. 7 at 1:00 AM
$HIMS $OZEM ....with around 35% of the float short and a P/E of 42.5.....How does this not drop to $9.00 on Monday?....If the lawyers do not eat up all their 'profits' quickly, then shareholders, unhappy with how mgmt headline grabbing news yesterday has "exposed" the company now to countless retail lawsuits, on the premise that the FDA had warned them prior about compounding a FDA regulated drug product w/o their stamp of approval...seems mgmt was not listening nor paying attention to the regulators when they had a fiduciary duty to "protect" shareholders...oh well...nobody likes to see other investors lose but mgmt at HIMS seems to have brought the hammer down on their and their shareholders head. glta
0 · Reply
wwmeinc
wwmeinc Feb. 6 at 4:32 PM
$OZEM $DJT $TSLA ...There is no limit to the bottomless pit that resides in DJT mind...truly an individual that if allowed, would gladly wear a KKK hood/robe with glee...truly a sick individual, in mind and soul....Nov.3rd/26 really not come fast enough...glta https://13wham.com/news/nation-world/trump-shares-a-racist-video-that-depicts-barack-michelle-obama-obamas-as-primates-truth-social-media-post
1 · Reply
StocktwitsNews
StocktwitsNews Feb. 5 at 3:58 PM
HIMS New $49 Pill Lifts Stock 10%, But Why Are NVO, LLY Stocks Falling? $HIMS $LLY $NVO $IHE $OZEM https://stocktwits.com/news/equity/markets/why-did-hims-stock-rise-but-nvo-lly-shares-fall/cZbZOVQR4Vs
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 4 at 2:02 PM
Novo Awaits FDA Call On Higher-Dose Wegovy In Early 2026 – NVO Stock Extends Decline Pre-Market On Weak Guidance $NVO $LLY $THNR $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-fda-higher-dose-wegovy-nvo-stock-outlook/cZbjThlR4ZM
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 4 at 12:14 PM
LLY Stock Surges Pre-Market: Obesity, Diabetes Drugs Drive Strong FY26 Outlook $LLY $LLYX $IHE $OZEM $THNR https://stocktwits.com/news/equity/markets/eli-lilly-lly-stock-jumps-fy26-guidance-zepbound-mounjaro/cZbSCjgR4Zl
0 · Reply
inspector_gadget86
inspector_gadget86 Feb. 3 at 5:41 PM
$AMGN $LLY $NVO $OZEM unexpectedly warning that fiscal 2026 sales will be hurt by lower drug prices in the U.S. even as it anticipates more patients will use its popular GLP-1 drug.
0 · Reply
TechForz
TechForz Jan. 24 at 4:58 PM
$OZEM 4th best performer in my portfolio over 12 months!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 6 at 12:58 AM
$OZEM RSI: 52.75, MACD: 0.7358 Vol: 0.74, MA20: 34.03, MA50: 31.83 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on OZEM
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space?

Jan 30, 2026, 9:32 AM EST - 24 days ago

OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space?

THNR

New Year, New Strategy: Navigating Weight Loss ETFs

Jan 12, 2026, 3:14 PM EST - 6 weeks ago

New Year, New Strategy: Navigating Weight Loss ETFs

HRTS THNR

Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch

Sep 12, 2024, 2:51 PM EDT - 1 year ago

Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch

CHAT MAGS

Why Investors Haven't Feasted on Two New Weight-Loss ETFs

Jun 24, 2024, 7:35 PM EDT - 1 year ago

Why Investors Haven't Feasted on Two New Weight-Loss ETFs

THNR

OZEM: Investing in the Weight Loss Craze

May 29, 2024, 12:01 PM EDT - 1 year ago

OZEM: Investing in the Weight Loss Craze

This new weight loss drug ETF bets big on two of the industry's leading players

May 27, 2024, 12:01 PM EDT - 1 year ago

This new weight loss drug ETF bets big on two of the industry's leading players

New funds jump on weight loss trade

May 21, 2024, 5:02 PM EDT - 1 year ago

New funds jump on weight loss trade

Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)

May 21, 2024, 9:00 AM EDT - 1 year ago

Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)

Roundhill to launch active weight loss ETF

May 20, 2024, 1:40 PM EDT - 1 year ago

Roundhill to launch active weight loss ETF

StocktwitsNews
StocktwitsNews Feb. 12 at 10:21 AM
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report $NVO $OZEM $PPH https://stocktwits.com/news/equity/markets/novo-looks-to-ireland-to-scale-production-of-wegovy-pill-report/cZRT0F6R4rc
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 10 at 2:59 PM
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial $HOTH $HIMS $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/hoth-therapeutics-gdnf-treatment-shows-superior-efficacy-over-wegovy-ozempic-in-preclinical-trial/cZbUJr3R4p2
0 · Reply
wwmeinc
wwmeinc Feb. 7 at 1:00 AM
$HIMS $OZEM ....with around 35% of the float short and a P/E of 42.5.....How does this not drop to $9.00 on Monday?....If the lawyers do not eat up all their 'profits' quickly, then shareholders, unhappy with how mgmt headline grabbing news yesterday has "exposed" the company now to countless retail lawsuits, on the premise that the FDA had warned them prior about compounding a FDA regulated drug product w/o their stamp of approval...seems mgmt was not listening nor paying attention to the regulators when they had a fiduciary duty to "protect" shareholders...oh well...nobody likes to see other investors lose but mgmt at HIMS seems to have brought the hammer down on their and their shareholders head. glta
0 · Reply
wwmeinc
wwmeinc Feb. 6 at 4:32 PM
$OZEM $DJT $TSLA ...There is no limit to the bottomless pit that resides in DJT mind...truly an individual that if allowed, would gladly wear a KKK hood/robe with glee...truly a sick individual, in mind and soul....Nov.3rd/26 really not come fast enough...glta https://13wham.com/news/nation-world/trump-shares-a-racist-video-that-depicts-barack-michelle-obama-obamas-as-primates-truth-social-media-post
1 · Reply
StocktwitsNews
StocktwitsNews Feb. 5 at 3:58 PM
HIMS New $49 Pill Lifts Stock 10%, But Why Are NVO, LLY Stocks Falling? $HIMS $LLY $NVO $IHE $OZEM https://stocktwits.com/news/equity/markets/why-did-hims-stock-rise-but-nvo-lly-shares-fall/cZbZOVQR4Vs
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 4 at 2:02 PM
Novo Awaits FDA Call On Higher-Dose Wegovy In Early 2026 – NVO Stock Extends Decline Pre-Market On Weak Guidance $NVO $LLY $THNR $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-fda-higher-dose-wegovy-nvo-stock-outlook/cZbjThlR4ZM
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 4 at 12:14 PM
LLY Stock Surges Pre-Market: Obesity, Diabetes Drugs Drive Strong FY26 Outlook $LLY $LLYX $IHE $OZEM $THNR https://stocktwits.com/news/equity/markets/eli-lilly-lly-stock-jumps-fy26-guidance-zepbound-mounjaro/cZbSCjgR4Zl
0 · Reply
inspector_gadget86
inspector_gadget86 Feb. 3 at 5:41 PM
$AMGN $LLY $NVO $OZEM unexpectedly warning that fiscal 2026 sales will be hurt by lower drug prices in the U.S. even as it anticipates more patients will use its popular GLP-1 drug.
0 · Reply
TechForz
TechForz Jan. 24 at 4:58 PM
$OZEM 4th best performer in my portfolio over 12 months!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 6 at 12:58 AM
$OZEM RSI: 52.75, MACD: 0.7358 Vol: 0.74, MA20: 34.03, MA50: 31.83 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Dec. 30 at 12:30 PM
$NVO's oral obesity pill just got FDA approval — a game changer in weight-loss drugs! 💊 🌟 First FDA-approved oral GLP-1 pill for chronic weight management in the U.S. 💰 Priced at $149/month, more accessible than injectables 📈 Participants lost 16.6% body weight in trials Discover why $OZEM, $THNR, and $PPH might be the smarter play here 👉 https://www.zacks.com/stock/news/2809629/the-obesity-pill-rush-healthcare-etfs-to-gain-as-fda-nods-to-novo-drug?cid=sm-stocktwits-2-2809629-body-26689&ADID=SYND_STOCKTWITS_TWEET_2_2809629_BODY_26689
0 · Reply
Europlus
Europlus Dec. 30 at 9:40 AM
$AMGN $LLY $NVO $OZEM What the fuck he is Talking about.
1 · Reply
inspector_gadget86
inspector_gadget86 Dec. 30 at 9:33 AM
$AMGN $LLY $NVO $OZEM What started with a focus on the drug’s ability to manage weight and combat related conditions such as heart disease, is now expanding further with growing interest in how it might also impact the brain.
0 · Reply
inspector_gadget86
inspector_gadget86 Dec. 30 at 9:33 AM
$AMGN $LLY $NVO $OZEM Scientists, however, say that Novo’s medicine still has potential.
0 · Reply
inspector_gadget86
inspector_gadget86 Dec. 30 at 9:32 AM
$AMGN $LLY $NVO $OZEM Novo Nordisk has had a difficult year as investors questioned the company’s ability to translate its strides in pioneering GLP-1 drugs to financial gains.
0 · Reply
inspector_gadget86
inspector_gadget86 Dec. 30 at 9:32 AM
$AMGN $LLY $NVO $OZEM Novo Nordisk’s ‘long game’ on weight loss drugs sparks hope in science, but the Street is impatient
0 · Reply
inspector_gadget86
inspector_gadget86 Dec. 30 at 9:26 AM
$AMGN $LLY $NVO $OZEM The stock’s ( $NVO) -to-date drop of 50% is being driven by increased competition from U.S. rival Eli Lilly and so-called compounding pharmacies making cheaper, copycat versions of semaglutide. A failure to convince investors that its pipeline will bring significant financial gains amid a flurry of hopeful market entrants also adds to the pressure.
0 · Reply
BloomBard
BloomBard Dec. 27 at 10:13 AM
$OZEM Positioning is increasingly shaped by how predictably management executes. Execution risk remains the main variable to watch. Evidence of repeatability could meaningfully alter perception. Future returns depend more on reliability than ambition.
0 · Reply
inspector_gadget86
inspector_gadget86 Oct. 10 at 4:43 PM
$AMGN $LLY $NVO $OZEM Ozempic and similar drugs could interfere with common medical procedure
1 · Reply
inspector_gadget86
inspector_gadget86 Sep. 29 at 7:54 PM
$JAVA $LLY $NVO $OZEM Weight-loss drugs now linked to cancer protection in women, major new study reveals
0 · Reply
inspector_gadget86
inspector_gadget86 Sep. 29 at 12:41 PM
$OZEM $LLY $NVO $JAVA weight loss prescription growth in the U.S. would slow down amid competitive pressures.
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 29 at 9:28 AM
Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today $NVO $OZEM $JAVA https://stocktwits.com/news/equity/markets/why-wegovy-maker-novo-nordisk-s-stock-is-sliding-3-premarket-today/chDMDwYR37q
0 · Reply